Prices shown are indicative dealer quotes, confirmed by our desk before any transaction.
Results update

NCDEX H1 FY27 Results: Loss Narrows to ₹21.6 Crore, but Other Income Still Does Heavy Lifting

NCDEX H1 FY27 consolidated results summary: revenue, other income and loss

Disclosure: UnlistedHub is a brand of Geincept Private Limited and has a commercial role in facilitating unlisted-share transactions. This article is for education, not a recommendation to buy or sell.

NCDEX's consolidated revenue from operations rose 41% to ₹54.96 crore in H1 FY27 and its loss narrowed to ₹21.60 crore. Nearly half of total income came from other income, major agri contracts remain suspended till March 2027, and ₹585.83 crore of its 2025 fundraise is still unspent.

The results at a glance

NCDEX Limited (formerly National Commodity & Derivatives Exchange Limited) approved its unaudited results for the quarter and half year ended 30 September 2026 at its board meeting on 13 November 2026. The figures below are consolidated (the exchange plus its subsidiaries and joint ventures), converted from ₹ lakh to ₹ crore.

₹ crore (consolidated) H1 FY27 H1 FY26 Change
Revenue from operations 54.96 38.89 +41.3%
Other income 46.39 22.74 +104.0%
Total income 101.35 61.63 +64.4%
Total expenses 130.92 100.83 +29.8%
Loss before tax (26.22) (37.80) narrower by 30.6%
Loss after tax (21.60) (28.03) narrower by 22.9%
Basic EPS (₹, not annualised) (2.37) (5.38) —

EPS is not directly comparable across the two periods: paid-up equity capital was ₹89.70 crore at 30 September 2026 against ₹50.68 crore a year earlier, after the preferential issue described below.

Quarter view: the second quarter loss was wider than the first

₹ crore (consolidated) Q2 FY27 Q1 FY27 Q2 FY26
Revenue from operations 28.82 26.13 19.49
Other income 21.90 24.48 11.72
Total expenses 66.84 64.08 51.22
Loss after tax (13.32) (8.30) (14.26)

Revenue from operations rose 10.3% from Q1 and 47.9% from Q2 FY26. But other income fell from Q1 while expenses kept rising, so the Q2 loss was about 60% larger than Q1's.

How much of the income came from the core business?

Two simple ratios (our calculation from the consolidated statement):

  • Other income as a share of total income: 45.8% in H1 FY27 (46.39 ÷ 101.35), up from 36.9% in H1 FY26 (22.74 ÷ 61.63).
  • Revenue from operations as a share of total expenses: 42.0% in H1 FY27 (54.96 ÷ 130.92), up from 38.6% in H1 FY26 (38.89 ÷ 100.83).

In plain words: the operating business is growing, but it still covers well under half of the group's costs, and nearly half of total income came from outside operations. The results statement does not itemise other income. Note 6 (below) shows where the unused fundraise money is currently invested.

Standalone vs consolidated

The standalone exchange (without subsidiaries) reported H1 FY27 revenue from operations of ₹18.89 crore (H1 FY26: ₹11.40 crore) and a loss after tax of ₹21.19 crore (H1 FY26: ₹21.71 crore). So the standalone loss barely changed, while the consolidated loss narrowed. When you compare numbers across websites, check which basis is being quoted.

What the notes to the results say

1. Major agri contracts are still suspended, now until 31 March 2027

Note 4 explains that, under SEBI directions, no fresh positions or new contracts have been allowed in chana and rapeseed-mustard since August and October 2021, and in certain other commodities, including soyabean and refined soy oil, under a circular of 20 December 2021. The suspension has been extended several times and now runs until 31 March 2027 (NCDEX circular dated 28 March 2026). The company says transaction-charge revenue from these commodities has been affected, and management sees no impact on the carrying value of its assets.

The statutory auditors, Khandelwal Jain & Co., drew attention to this note in an emphasis of matter paragraph. Their review conclusion is not modified.

2. The ₹770 crore raise: how much has been used

Note 6: NCDEX allotted 3,90,18,973 equity shares at ₹197.34 each (face value ₹10) on 7 October 2025, raising ₹770 crore on a preferential basis. These shares carry a 12-month lock-in from the allotment date. Net proceeds were ₹761.83 crore, meant mainly for entry into the equity and equity derivatives segments (SEBI gave in-principle approval on 29 July 2025, per note 4).

Use of proceeds (₹ crore) Up to 31 Mar 2026 Up to 30 Sep 2026
Spent on the equity and equity derivatives segment 14.67 176.00
Unutilised, temporarily invested — 585.83

At 30 September 2026 the unutilised ₹585.83 crore sat in debt mutual funds (₹356.89 crore), fixed deposits (₹78.66 crore) and corporate bonds (₹150.28 crore). The three add up to the unutilised total.

3. Deferred tax assets of ₹48.88 crore

Note 5: NCDEX (standalone) has recognised deferred tax assets of ₹48.88 crore (₹43.35 crore at 31 March 2026) on business losses and unabsorbed depreciation, based on management's expectation of future taxable profits under its approved business plan. The auditors also highlighted this note in an emphasis of matter paragraph. A deferred tax credit is one reason the loss after tax is smaller than the loss before tax.

4. Mutual fund platform launched

Note 7: after final SEBI approval on 20 July 2026, NCDEX launched its "NCDEX Nidhi" mutual fund platform on 29 July 2026.

Review status

These are unaudited results that went through a limited review, not a full audit. A limited review gives moderate assurance only: the auditor makes enquiries and runs analytical checks, but does not express an audit opinion.

What to watch (from the filing, not a forecast)

  • Whether the commodity suspension is lifted or extended again after 31 March 2027.
  • How quickly the remaining ₹585.83 crore is deployed into the equity segment, and any further regulatory approvals for that segment.
  • Whether other income keeps covering a large share of costs as the invested surplus is spent.
  • The December quarter results.

Limitations

Figures are taken from the scanned results PDF and converted from ₹ lakh to ₹ crore (÷100), rounded to two decimals. Percentages and ratios are our own calculations from the reported figures. This article explains a public filing and is not a recommendation to buy, sell or hold any security.

See the NCDEX share page on UnlistedHub for company details, and our guide to documents to check before an unlisted share transfer.

Primary sources

Unlisted shares can be illiquid and can lose part or all of their value. This article gives no price target or view on whether to invest. See the National Commodity & Derivatives Exchange Limited share page for identifiers, filed financials and today's indicative price, and our unlisted-share comparison checklist.